Ustekinumab as an Effective Therapeutic Option in Papillon–Lefèvre Syndrome: Long‐Term Follow‐Up

Ozlem Apti Sengkioun, Deniz Yücelten, Tülin Ergun

Open source

DOI: 10.1111/pde.70351
Published: 2026-09-02
Container: Pediatric Dermatology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/pde.70351,
  title = {Ustekinumab as an Effective Therapeutic Option in Papillon–Lefèvre Syndrome: Long‐Term Follow‐Up},
  author = {Ozlem Apti Sengkioun and Deniz Yücelten and Tülin Ergun},
  year = {2026},
  journal = {Pediatric Dermatology},
  doi = {10.1111/pde.70351},
  url = {https://doi.org/10.1111/pde.70351}
}

RIS

TY  - JOUR
TI  - Ustekinumab as an Effective Therapeutic Option in Papillon–Lefèvre Syndrome: Long‐Term Follow‐Up
AU  - Ozlem Apti Sengkioun
AU  - Deniz Yücelten
AU  - Tülin Ergun
PY  - 2026
JO  - Pediatric Dermatology
DO  - 10.1111/pde.70351
UR  - https://doi.org/10.1111/pde.70351
ER  -

APA

Sengkioun, O. A., Yücelten, D., & Ergun, T. (2026). Ustekinumab as an Effective Therapeutic Option in Papillon–Lefèvre Syndrome: Long‐Term Follow‐Up. Pediatric Dermatology. https://doi.org/10.1111/pde.70351

Source records

crossref · retrieved 2026-09-25T04:02:06.740Z